Rahul Karna

Rahul Karna

Auto-generated profile, based on publicly available information

Rahul Karna

Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Minnesota, Minneapolis, MN

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Current Treatment Options in Infectious Diseases
Verified
Journal Article
Closed access
PDF file
PKpremashish kar
premashish kar
RKR. Karna
R. Karna

1 November 2018 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
CWCassie Wicken
Cassie Wicken
JNJames Nguyen
James Nguyen
RKRahul Karna
Rahul Karna
PBPavan Bhargava
Pavan Bhargava

17 July 2024 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
JPJennifer Phan
Jennifer Phan
PCPatrick Chang
Patrick Chang
DIDanny Issa
Danny Issa
RTRonald Turner
Ronald Turner
JDJennifer Dodge
Jennifer Dodge
TTThomas Tielleman
Thomas Tielleman
INTRODUCTION: While ubiquity of glucagon-like peptide receptor agonists (GLP1-RAs) is rising, guidance from the gastroenterology societies and American Society of Anesthesiologist (ASA) remains in conflict on recommendations regarding preoperative holding before endoscopy. The aim of this study was to address this by evaluating the effect of GLP1-RAs on gastric retention during upper endoscopy. METHODS: This multicenter cross-sectional study included patients on confirmed GLP1-RAs receiving an endoscopy from 2021 to 2023. Demographics, prescribing practices, and procedure outcomes were captured. GLP1-RA management of preoperative holding was retroactively classified per ASA guidance. Multivariable logistic regression was performed to assess factors influencing retained gastric contents. RESULTS: Of 815 patients, 70 (8.7%) had retained gastric contents on endoscopy of whom 65 (93%) had type 2 diabetes mellitus. Only 1 (1.4%) of these patients required unplanned intubation, and none had aspiration events. Those with GLP1-RA held per ASA guidance (406, 49.8%) were less likely to have retained contents (4.4% vs 12.7%, P < 0.001), but there were no significant differences to intubation (0% vs 2%, P = 0.53) or aborting procedure rates (28% vs 18%, P = 0.40) due to gastric retention. On multivariable analysis, likelihood of food retention increased 36% (95% confidence interval 1.15–1.60) for every 1% increase in hemoglobin A1C after adjusting for GLP1-RA type and preoperative medication hold. DISCUSSION: In this multicenter study, very low rates of retained gastric contents were seen during endoscopy in patients on GLP1-RAs and most were in patients with type 2 diabetes mellitus. Our findings suggest an individualized approach rather than universal preoperative holding of medications before endoscopy.

1 March 2020 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
RKRahul Karna
Rahul Karna
RHRajib K. Hazam
Rajib K. Hazam
JBJayanta Borkakoti
Jayanta Borkakoti
AKAshok Kumar
Ashok Kumar
PKpremashish kar
premashish kar

1 January 2024 in Clinical Liver Disease
Verified
Journal Article
Closed access
RKRahul Karna
Rahul Karna
MBMichael Babich
Michael Babich
Export

16 May 2023 in Immunotherapy
Verified
Journal Article
Closed access
RKRahul Karna
Rahul Karna
SDSmit S Deliwala
Smit S Deliwala
BRBalasubramanian Ramgopal
Balasubramanian Ramgopal
PAPalash Asawa
Palash Asawa
RMRahul Mishra
Rahul Mishra
DADouglas G Adler
Douglas G Adler
Introduction: Combined immune checkpoint inhibitors can cause gastrointestinal adverse events. Methods: We performed a meta-analysis of pooled colonic, hepatic and pancreatic treatment-related adve... Plain language summary The article talks about a type of medicine called immune checkpoint inhibitors that are used to treat cancer. These medicines can sometimes cause problems in the stomach and ...